US Broker Ratings

Novo Nordisk A/S (NVO) Stock Analysis: Examining a Healthcare Giant with a 4.17% Dividend Yield and Strong Upside Potential

Novo Nordisk A/S (NYSE: NVO), a leading name in the healthcare sector, continues to captivate investors with its strong market presence and robust financial metrics. As..

Bausch + Lomb (BLCO) Stock Analysis: Eye Health Giant with a 10.37% Potential Upside

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the global eye health industry, commands the attention of investors with its robust market presence and promising..

Qiagen N.V. (QGEN) Stock Analysis: A Balanced Outlook in the Diagnostics Sector

Qiagen N.V. (NYSE: QGEN), a prominent player in the healthcare sector, operates within the diagnostics and research industry. Headquartered in Venlo, Netherlands, Qiagen is known for..

RadNet, Inc. (RDNT) Stock Analysis: A 25% Upside Potential with Strong Buy Ratings

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector specializing in diagnostics and research, is drawing attention from investors for its robust growth potential..

Humana Inc. (HUM) Stock Analysis: Exploring Growth Potential Amid Strong Revenue Growth

Humana Inc. (NYSE: HUM), a prominent player in the healthcare sector, particularly in healthcare plans, stands out with a robust market capitalization of $49.21 billion. As..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a 10.92% Potential Downside Amidst Healthcare Sector Innovations

Bio-Rad Laboratories, Inc. (NYSE: BIO) stands as a prominent player in the healthcare sector, specifically within the medical devices industry. Headquartered in Hercules, California, the company..

Ionis Pharmaceuticals (IONS) Stock Analysis: Biotechnology Player with 55% Upside Potential and Strong Analyst Confidence

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) operates at the forefront of the biotechnology sector, specializing in RNA-targeted medicines. Despite the challenges reflected in its recent financial performance,..

Bruker Corporation (BRKR) Stock Analysis: Evaluating Growth Potential with a 10.86% Upside

Bruker Corporation (NASDAQ: BRKR), a key player in the healthcare sector specializing in medical devices, offers investors an intriguing opportunity with a projected potential upside of..

AbbVie Inc. (ABBV) Stock Analysis: A $454 Billion Giant with Upside Potential and Strong Buy Ratings

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, continues to capture investor attention with its robust portfolio and promising growth trajectory. Operating within the..

Medpace Holdings, Inc. (MEDP) Stock Analysis: A Resilient Growth Story with a Strong ROE

Medpace Holdings, Inc. (NASDAQ: MEDP) is carving out a formidable presence in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unveiling an 18% Potential Upside in Healthcare Solutions

Stevanato Group S.p.A. (STVN), a prominent player in the healthcare sector, is drawing attention from investors with a significant 18.06% potential upside in its stock price...

Oscar Health, Inc. (OSCR) Stock Analysis: Riding a 70.4% Revenue Growth Wave in the Healthcare Sector

Oscar Health, Inc. (NYSE: OSCR) has made waves in the healthcare sector with its innovative approach to health insurance and technology integration. Operating in the U.S...

Tempus AI, Inc. (TEM): Investor Outlook with a 15.53% Upside Potential

Tempus AI, Inc. (NASDAQ: TEM), a prominent player in the healthcare technology sector, is drawing attention from investors due to its innovative platforms and strategic partnerships...

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating Market Challenges with a 17.97% ROE

Inspire Medical Systems, Inc. (NASDAQ: INSP) continues to capture the attention of investors within the healthcare sector, particularly those focused on medical devices. With a market..

Legend Biotech Corporation (LEGN) Stock Analysis: Exploring a 160% Potential Upside with Innovative Therapies

For investors with an eye on the healthcare sector, Legend Biotech Corporation (NASDAQ: LEGN) presents a compelling opportunity, especially considering the staggering 160.08% potential upside based..

AptarGroup, Inc. (ATR) Investor Outlook: Assessing a 36% Potential Upside in the Healthcare Sector

AptarGroup, Inc. (NYSE: ATR), a prominent player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $7.94 billion,..

Elanco Animal Health (ELAN) Stock Analysis: Exploring a 34.72% Potential Upside

Elanco Animal Health Incorporated (NYSE: ELAN), a key player in the healthcare sector specializing in animal health, presents an intriguing opportunity for investors with its significant..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Gem with a 29% Upside Potential

TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the biotechnology sector, has garnered significant attention with its strategic focus on B-cell mediated diseases. With a..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 43.91% Potential Upside Amidst a Challenging Market

Grifols, S.A. (NASDAQ: GRFS), a key player in the healthcare sector specializing in the manufacture of plasma-derived medicines, stands at a pivotal point in its market..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: A Promising 58% Upside for Healthcare Innovators

iRhythm Holdings, Inc. (NASDAQ: IRTC) presents an intriguing opportunity for investors, particularly those interested in the healthcare sector’s innovative edge. This San Francisco-based company specializes in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds